Spero Therapeutics Inc - SPRO Earnings per one share for the last 12 months

Official company branding of Spero Therapeutics Inc (SPRO)

This daily price chart for Spero Therapeutics (SPRO) on the GURU.Markets platform, where EPS is 38.70, reflects the price action of a biopharmaceutical company whose antibiotic supplies depend on the stability of Asian logistics. A team of top-tier medical professionals is developing socially critical medicines in exchange for stock options. However, strict FDA oversight and inconsistent payments from counterparties render the company's cash flows volatile.

Spero Therapeutics, Inc. (SPRO): Net earnings per share (EPS TTM) from 02/11/2024 to 11/16/2026

sperotherapeutics.com - analytical breakdowns and key metrics (SPRO)

- share price and consensus valuation forecast:
- issuer market value details:
Initial company analysis:SPRO, Spero Therapeutics Inc
Manufactured products of Spero Therapeutics

To minimize risks when building a position, it is essential to track the rolling year earnings per share trend, which identifies structural shifts in business profitability by measuring the annual growth of EPS TTM. For Spero Therapeutics (SPRO), this indicator reflects the monetization of unique antibiotics against resistant infections, confirming the company's pricing power and the fundamental stability of its operating model.